首页> 美国卫生研究院文献>Clinical Molecular Pathology >The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders
【2h】

The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders

机译:免疫球蛋白和T细胞受体基因重排的分子分析在淋巴增生性疾病诊断中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aims—To investigate whether the analysis of immunoglobulin (Ig)/T cell receptor (TCR) rearrangements is useful in the diagnosis of lymphoproliferative disorders. Methods—In a series of 107 consecutive cases with initial suspicion of non-Hodgkin's lymphoma (NHL), Southern blot (SB) analysis of Ig/TCR rearrangements was performed. Results—In 98 of 100 histopathologically conclusive cases, Ig/TCR gene results were concordant. In one presumed diffuse large B cell lymphoma (DLCL) and one follicular lymphoma (FL) case no clonality could be detected by SB analysis, or by polymerase chain reaction (PCR) at second stage. In the DLCL, sampling error might have occurred; the FL was revised after an initial diagnosis of reactivity. In many of the histopathologically inconclusive cases Ig/TCR gene SB analysis was helpful, giving support for the histopathological suspicion. However, because of a lack of (clinical) follow up data this could not be confirmed in a few cases. Conclusions—Experienced haematopathologists or a pathologist panel can diagnose malignant versus reactive lesions in most cases without the need for Ig/TCR gene analysis and can select the 5–10% of cases that might benefit from molecular clonality studies. >Key Words: B cell lymphoma • immunoglobulin and T cell receptor genes • clonality analysis • Southern blotting
机译:目的—研究免疫球蛋白(Ig)/ T细胞受体(TCR)重排的分析是否可用于诊断淋巴增生性疾病。方法-在最初怀疑为非霍奇金淋巴瘤(NHL)的一系列连续107例病例中,对Ig / TCR重排进行了Southern blot(SB)分析。结果:在100例组织病理学确诊病例中,有98例Ig / TCR基因结果一致。在一个假定的弥漫性大B细胞淋巴瘤(DLCL)和一个滤泡性淋巴瘤(FL)病例中,在第二阶段通过SB分析或聚合酶链反应(PCR)无法检测到克隆性。在DLCL中,可能发生了采样错误。在对反应性进行初步诊断后,对FL进行了修订。在许多没有组织病理学结论的病例中,Ig / TCR基因SB分析是有帮助的,为组织病理学怀疑提供了支持。但是,由于缺乏(临床)随访数据,因此在少数情况下无法确认。结论-有经验的血液病理学家或病理学家小组可以在大多数情况下诊断出恶性或反应性病变,而无需进行Ig / TCR基因分析,并且可以选择5-10%的受益于分子克隆研究的病例。 >关键词: B细胞淋巴瘤•免疫球蛋白和T细胞受体基因•克隆性分析•Southern印迹

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号